Post-COVID POTS: 1 in 5 cases now seen in primary care. · The Monday Briefing, 7 September 2026

The week's most important clinical updates, curated for healthcare professionals.
Having trouble viewing the newsletter?   Open in browser
The Life Science Feed Therapy Areas Disease Areas Events
Weekly Edition #37/26
September 7, 2026  ·  Weekly Newsletter
Good morning, Reader.

This week, we see a striking paradox in how we manage complex, long-term conditions. While **Post-COVID Dysautonomia** forces GPs to navigate poorly defined syndromes, new data provides clear, actionable steps in other areas. The gap between established diagnostics and emerging illnesses remains wide.

1. **Post-COVID POTS Diagnosis**, General practitioners are increasingly identifying postural orthostatic tachycardia syndrome (POTS) as a sequela of SARS-CoV-2 infection, demanding a broader differential diagnosis. Clinicians need clearer pathways. 2. **Tirzepatide for OSA**, The SURMOUNT-OSA trial data shows tirzepatide reduces the apnea-hypopnea index in obstructive sleep apnea patients. This creates a new therapeutic option. 3. **ADPKD Progression Risk**, The Mayo imaging classification offers a practical tool for identifying autosomal dominant polycystic kidney disease patients at high risk of rapid progression. This guides targeted intervention.

This cluster of evidence reveals a dual reality: some complex conditions are finally yielding to precise, measurable interventions, while others, like long COVID, still rely on astute clinical observation without definitive biomarkers. We are still learning to manage the fallout from new diseases.

Clinicians must balance the drive for precise, data-driven interventions with the ongoing need for careful, patient-centred observation in ambiguous cases. I read every reply.

Long COVID Neurological
The lingering effects of SARS-CoV-2 infection continue to present complex clinical pictures, with post-COVID dysautonomia emerging as a significant and often debilitating sequela. General practitioners face the task of identifying these autonomic nervous system dysfunctions, particularly postural orthostatic tachycardia syndrome (POTS), amidst a broad differential diagnosis. Understanding the clinical presentation and diagnostic approach is critical for effective patient care.
Continue Reading →
This week
Latest Updates
View all →
Obstructive Sleep Apnea
Tirzepatide in OSA: What SURMOUNT-OSA means...
Read article →
Polycystic Kidney Disease
Identifying rapid progressors in ADPKD: The...
Read article →
 
Rosacea
Does targeting Demodex mites improve rosacea...
Read article →
Crystal Arthropathies
Crystal Arthritis: The ICU Fever You Keep...
Read article →
 
Acne Vulgaris
Intravenous Immunoglobulin for...
Read article →
Beta-Thalassemia
Iron chelation in gene therapy: When to...
Read article →
 
Benign Prostatic Hyperplasia
BPH treatment: The sexual side effects...
Read article →
Personality Disorders
Borderline personality disorder: where...
Read article →
 
Congress Coverage
Follow the science, live.
Real-time coverage from leading medical congresses: summaries, key data, and expert commentary.
Sep 28 – Oct 2, 2026  ·  Milan
Allianz MiCo - Milan Convention Centre
EASD 2026: EASD Annual Meeting 2026
View Coverage →
Oct 17 – 20, 2026  ·  Barcelona
Fira Barcelona Gran Via, North Entrance, Av. Joan Carles I 64, 08908 Hospitalet de Llobregat, Barcelona, Spain
UEG Week 2026: United European Gastroenterology Week 2026
View Coverage →
Oct 21 – 23, 2026  ·  Toronto
Metro Toronto Convention Center
Joint ACTRIMS-ECTRIMS 2026: 10th Joint ACTRIMS-ECTRIMS Global Meeting MSToronto 2026
View Coverage →
Podcast Spotlight
Heart Failure Deep Dive Series · EP 4
Listen Now →
 
Special Reports LSF Intelligence Series
LSF Special Reports
In-depth briefings from the LSF Intelligence Series, co-authored by Mara Voss and the LSF Editorial Team. Each report covers the trial data, the clinical context, and what it means in practice.
Browse All Reports →
Personalise your feed
Get content tailored to your specialty.
Set your therapy area →
Intended Audience This publication is intended for healthcare professionals, researchers, and life science industry professionals. Content is provided for informational and educational purposes only and does not constitute medical advice.
Press Credentials The Life Science Feed holds accredited press credentials for major international medical and scientific congresses across cardiology, oncology, pulmonology, neurology, rheumatology, and more. View our press accreditations →
© 2025–2026 The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
LSF-QYJEBH-NL-GEN-W3726
You are receiving this because you subscribed at thelifesciencefeed.com. Under GDPR, you have the right to access, correct, or delete your personal data at any time.

View as sent →

Read the full archive

    0:00 / 0:00